| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M604550200 |
| P698 | PubMed publication ID | 16754662 |
| P50 | author | David Craik | Q37375333 |
| David J. Adams | Q37829157 | ||
| Richard J. Clark | Q37375290 | ||
| Harald Fischer | Q5653759 | ||
| P2093 | author name string | Simon T Nevin | |
| P2860 | cites work | 1H, 13C and 15N random coil NMR chemical shifts of the common amino acids. I. Investigations of nearest-neighbor effects | Q29616506 |
| P433 | issue | 32 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 23254-23263 | |
| P577 | publication date | 2006-06-05 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1. | |
| P478 | volume | 281 |
| Q34575566 | A novel inhibitor of α9α10 nicotinic acetylcholine receptors from Conus vexillum delineates a new conotoxin superfamily. |
| Q27681218 | A novel 4/7-conotoxin LvIA from Conus lividus that selectively blocks 3 2 vs. 6/ 3 2 3 nicotinic acetylcholine receptors |
| Q30878761 | A synthetic combinatorial strategy for developing alpha-conotoxin analogs as potent alpha7 nicotinic acetylcholine receptor antagonists |
| Q27646907 | AChBP-targeted α-conotoxin correlates distinct binding orientations with nAChR subtype selectivity |
| Q33621205 | Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors |
| Q37336577 | Alpha9 nicotinic acetylcholine receptors and the treatment of pain |
| Q44676738 | Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. |
| Q36159142 | Analgesic conotoxins: block and G protein-coupled receptor modulation of N-type (Ca(V) 2.2) calcium channels |
| Q64076290 | Antibodies and venom peptides: new modalities for ion channels |
| Q33782635 | Atypical alpha-conotoxin LtIA from Conus litteratus targets a novel microsite of the alpha3beta2 nicotinic receptor |
| Q38175134 | Calcium-permeable ion channels in pain signaling |
| Q34156116 | Chemical synthesis and characterization of two α4/7-conotoxins |
| Q39424563 | Concomitant facilitation of GABAA receptors and KV7 channels by the non-opioid analgesic flupirtine. |
| Q35432836 | Cone snail venomics: from novel biology to novel therapeutics |
| Q26783037 | Conotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management? |
| Q33736765 | Conotoxins targeting nicotinic acetylcholine receptors: an overview |
| Q30367509 | Constraining cyclic peptides to mimic protein structure motifs. |
| Q64074559 | Crystal Structure of the Monomeric Extracellular Domain of α9 Nicotinic Receptor Subunit in Complex With α-Conotoxin RgIA: Molecular Dynamics Insights Into RgIA Binding to α9α10 Nicotinic Receptors |
| Q48198015 | Cyclic analogues of α-conotoxin Vc1.1 inhibit colonic nociceptors and provide analgesia in a mouse model of chronic abdominal pain |
| Q37677444 | Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation |
| Q58097124 | Discovery Methodology of Novel Conotoxins from Species |
| Q28481593 | Discovery of defense- and neuropeptides in social ants by genome-mining |
| Q33693128 | Disulfide Bond Assignments by Mass Spectrometry of Native Natural Peptides: Cysteine Pairing in Disulfide Bonded Conotoxins |
| Q35063148 | Embryonic toxin expression in the cone snail Conus victoriae: primed to kill or divergent function? |
| Q39234026 | Enhancing the therapeutic potential of peptide toxins |
| Q37954330 | From toxins targeting ligand gated ion channels to therapeutic molecules |
| Q47104016 | G-Protein Coupled Receptors Targeted by Analgesic Venom Peptides |
| Q33400496 | High throughput electrophysiology with Xenopus oocytes |
| Q37348886 | Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors. |
| Q35974234 | Less is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1. |
| Q35735112 | Limited efficacy of α-conopeptides, Vc1.1 and RgIA, to inhibit sensory neuron CaV current |
| Q46272595 | Molecular Engineering of Conus Peptides as Therapeutic Leads |
| Q24673308 | Molecular mechanism for analgesia involving specific antagonism of alpha9alpha10 nicotinic acetylcholine receptors |
| Q64250595 | Mutagenesis of α-Conotoxins for Enhancing Activity and Selectivity for Nicotinic Acetylcholine Receptors |
| Q37978834 | NMR as an effective tool for the structure determination of lasso peptides |
| Q37590093 | Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system |
| Q35853738 | Novel small molecule α9α10 nicotinic receptor antagonist prevents and reverses chemotherapy-evoked neuropathic pain in rats |
| Q94568897 | On-resin strategy to label α-conotoxins: Cy5-RgIA, a potent α9α10 nicotinic acetylcholine receptor imaging probe |
| Q50111328 | Potential Uses of Isolated Toxin Peptides in Neuropathic Pain Relief: A Literature Review |
| Q39897555 | Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives |
| Q36507136 | Recombinant Expression and Characterization of α-Conotoxin LvIA in Escherichia coli. |
| Q28075856 | Residues Responsible for the Selectivity of α-Conotoxins for Ac-AChBP or nAChRs |
| Q55712030 | Role of CysI–CysIII Disulfide Bond on the Structure and Activity of α-Conotoxins at Human Neuronal Nicotinic Acetylcholine Receptors. |
| Q37339057 | Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor |
| Q37077635 | Strategies for the development of conotoxins as new therapeutic leads |
| Q92989648 | Structural and Functional Analyses of Cone Snail Toxins |
| Q34695631 | Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels |
| Q37954299 | Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads |
| Q30494943 | The alpha 3 subunit gene of the nicotinic acetylcholine receptor is a candidate gene for ethanol stimulation |
| Q46777407 | The three-dimensional structure of the analgesic alpha-conotoxin, RgIA. |
| Q33369942 | Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function |
| Q34777866 | Understanding the structure/activity relationships of the iron regulatory peptide hepcidin |
| Q33809867 | Use of venom peptides to probe ion channel structure and function |
| Q39405111 | α9-containing nicotinic acetylcholine receptors and the modulation of pain. |
| Q34333395 | α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia |
| Q36078883 | γ-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins |
Search more.